• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Reduction of tumor blood flow by flavone acetic acid: a possible component of therapy.

作者信息

Bibby M C, Double J A, Loadman P M, Duke C V

机构信息

United Kingdom, Clinical Oncology Unit, University of Bradford, United Kingdom.

出版信息

J Natl Cancer Inst. 1989 Feb 1;81(3):216-20. doi: 10.1093/jnci/81.3.216.

DOI:10.1093/jnci/81.3.216
PMID:2911084
Abstract

Flavone acetic acid (FAA) is active against normally refractory murine sc tumors. Clinical studies are disappointing despite achievement of plasma profiles associated with the antitumor murine activity in man. To clarify the mechanism of action, we have followed histologic changes, tumor blood volume, and drug concentrations in a well-differentiated, slow-growing cystic adenocarcinoma in mice. FAA causes massive tumor necrosis beginning 2 hours after treatment. Tumor plasma volumes are reduced by 2 hours after treatment and tumor blood vessels are shutdown, which suggests that tumor vasculature plays a role in the dramatic response of sc tumors in pure-strain male NMRI mice.

摘要

相似文献

1
Reduction of tumor blood flow by flavone acetic acid: a possible component of therapy.
J Natl Cancer Inst. 1989 Feb 1;81(3):216-20. doi: 10.1093/jnci/81.3.216.
2
Blood flow failure as a major determinant in the antitumor action of flavone acetic acid.血流衰竭是黄酮乙酸抗肿瘤作用的主要决定因素。
J Natl Cancer Inst. 1989 Jul 5;81(13):1005-13. doi: 10.1093/jnci/81.13.1005.
3
Enhancement of the antitumor effect of flavone acetic acid by the bioreductive cytotoxic drug SR 4233 in a murine carcinoma.生物还原细胞毒性药物SR 4233增强黄酮乙酸对小鼠癌的抗肿瘤作用
Cancer Res. 1989 Oct 15;49(20):5664-70.
4
Vascular collapse after flavone acetic acid: a possible mechanism of its anti-tumour action.黄酮乙酸所致的血管塌陷:其抗肿瘤作用的一种可能机制。
Eur J Cancer Clin Oncol. 1989 Oct;25(10):1419-24. doi: 10.1016/0277-5379(89)90099-0.
5
Role of tumor necrosis factor in flavone acetic acid-induced tumor vasculature shutdown.肿瘤坏死因子在黄酮乙酸诱导的肿瘤血管关闭中的作用。
Cancer Res. 1990 Sep 1;50(17):5537-42.
6
Anti-tumour activity of flavone acetic acid (NSC 347512) in mice--influence of immune status.黄酮醋酸(NSC 347512)对小鼠的抗肿瘤活性——免疫状态的影响
Br J Cancer. 1991 Jan;63(1):57-62. doi: 10.1038/bjc.1991.12.
7
Influence of site on the chemosensitivity of transplantable murine colon tumours to flavone acetic acid (LM975, NSC 347512).部位对可移植性小鼠结肠肿瘤对黄酮乙酸(LM975,NSC 347512)化学敏感性的影响。
Cancer Chemother Pharmacol. 1989;24(2):87-94. doi: 10.1007/BF00263126.
8
Anti-vascular approaches to solid tumour therapy: evaluation of vinblastine and flavone acetic acid.实体瘤治疗的抗血管生成方法:长春碱和黄酮乙酸的评估
Int J Cancer. 1995 Sep 27;63(1):119-23. doi: 10.1002/ijc.2910630121.
9
Pharmacodynamics and causes of dose-dependent pharmacokinetics of flavone-8-acetic acid (LM-975; NSC-347512) in mice.黄酮 -8 - 乙酸(LM - 975;NSC - 347512)在小鼠体内的药效学及剂量依赖性药代动力学原因
Cancer Chemother Pharmacol. 1989;24(1):15-22. doi: 10.1007/BF00254099.
10
Flavone acetic acid stimulates nitric oxide and peroxynitrite production in subcutaneous mouse tumors.黄酮乙酸刺激皮下小鼠肿瘤中一氧化氮和过氧亚硝酸盐的产生。
Biochem Biophys Res Commun. 1997 Jun 27;235(3):509-14. doi: 10.1006/bbrc.1997.6820.

引用本文的文献

1
Identification and induction of cytochrome P450s involved in the metabolism of flavone-8-acetic acid in mice.小鼠中参与黄酮 - 8 - 乙酸代谢的细胞色素P450的鉴定与诱导
Drug Metab Lett. 2011 Apr;5(2):73-84. doi: 10.2174/187231211795305221.
2
Antivascular effects of TZT-1027 (Soblidotin) on murine Colon26 adenocarcinoma.TZT-1027(索布力多汀)对小鼠结肠26腺癌的抗血管生成作用。
Cancer Sci. 2006 Dec;97(12):1410-6. doi: 10.1111/j.1349-7006.2006.00330.x. Epub 2006 Sep 25.
3
Professor Tom Connors and the development of novel cancer therapies by the Phase I/II Clinical Trials Committee of Cancer Research UK.
汤姆·康纳斯教授与英国癌症研究中心I/II期临床试验委员会新型癌症疗法的研发。
Br J Cancer. 2003 Aug 4;89(3):437-54. doi: 10.1038/sj.bjc.6601106.
4
5,6-dimethylxanthenone-4-acetic acid (DMXAA): a new biological response modifier for cancer therapy.5,6-二甲基呫吨酮-4-乙酸(DMXAA):一种用于癌症治疗的新型生物反应调节剂。
Invest New Drugs. 2002 Aug;20(3):281-95. doi: 10.1023/a:1016215015530.
5
A novel combretastatin A-4 derivative, AC7700, strongly stanches tumour blood flow and inhibits growth of tumours developing in various tissues and organs.一种新型的秋水仙素A-4衍生物AC7700能强力阻止肿瘤血流,并抑制在各种组织和器官中生长的肿瘤。
Br J Cancer. 2002 May 20;86(10):1604-14. doi: 10.1038/sj.bjc.6600296.
6
The biology of the combretastatins as tumour vascular targeting agents.作为肿瘤血管靶向剂的考布他汀生物学特性。
Int J Exp Pathol. 2002 Feb;83(1):21-38. doi: 10.1046/j.1365-2613.2002.00211.x.
7
Hypoxia-inducible regulation of a prodrug-activating enzyme for tumor-specific gene therapy.用于肿瘤特异性基因治疗的前药激活酶的缺氧诱导调节。
Neoplasia. 2002 Jan-Feb;4(1):40-8. doi: 10.1038/sj.neo.7900189.
8
Tumor-selective blood flow decrease induced by an angiotensin converting enzyme inhibitor, temocapril hydrochloride.血管紧张素转换酶抑制剂盐酸替莫卡普利诱导的肿瘤选择性血流减少
Jpn J Cancer Res. 2000 Feb;91(2):261-9. doi: 10.1111/j.1349-7006.2000.tb00940.x.
9
Evaluation of antivascular and antimitotic effects of tubulin binding agents in solid tumor therapy.微管蛋白结合剂在实体瘤治疗中的抗血管生成和抗有丝分裂作用评估。
Jpn J Cancer Res. 1999 Dec;90(12):1387-95. doi: 10.1111/j.1349-7006.1999.tb00724.x.
10
In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug.秋水仙素 A-4 及其磷酸钠前药的体内和体外评价。
Br J Cancer. 1999 Dec;81(8):1318-27. doi: 10.1038/sj.bjc.6692174.